-
Mashup Score: 2Focal Therapy for Prostate Cancer: Evidence-Based or Oversold? - 3 month(s) ago
Despite growing enthusiasm for this minimally invasive option for some men with prostate cancer, focal therapy is still not FDA-approved for prostate cancer and comes with high out-of-pocket costs.
Source: www.medscape.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Plant-Based Diet a Boon for Men With Prostate Cancer - 3 month(s) ago
New data showed men who eat more fruits and vegetables enjoyed better quality of life, including sexual function.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Adding Apalutamide Boosts PSA Control in Prostate Cancer - 3 month(s) ago
Adding apalutamide to androgen deprivation therapy (ADT) prolongs prostate-specific antigen progression-free survival in patients with biochemically recurrent prostate cancer.
Source: www.medscape.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6Higher-Dose RT Extends Survival in High-Risk Prostate Cancer - 3 month(s) ago
Adding higher dose radiation led to long-term ADT led to better progression-free, cancer-specific, and overall survival vs standard-dose radiation in men with high-risk prostate cancer.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4Active Surveillance Preferred in Low-Risk Prostate Cancer - 6 month(s) ago
When informed about treatment options, most men with low-risk prostate cancer chose active surveillance instead of active therapy in a recent Italy-based analysis.
Source: www.medscape.comCategories: General Medicine News, General NewsTweet
Focal therapy for #prostatecancer: Evidence-based or oversold? #MedTwitter https://t.co/bF9EDHY9I9 https://t.co/jVvdykiMlO